Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Terazosin for benign prostatic hyperplasia.
T. J. Wilt
, R. W. Howe
, I. R. Rutks
, R. MacDonald
Medicine - Veteran's Administration Medical Center
Research output
:
Contribution to journal
›
Review article
›
peer-review
42
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Terazosin for benign prostatic hyperplasia.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Benign Prostatic Hyperplasia
100%
Terazosin
100%
Placebo
90%
Alpha-blockers
60%
Benign Prostatic Obstruction
60%
Finasteride
60%
Adverse Effects
50%
Symptom Score
50%
α-antagonist
30%
Placebo-controlled
20%
Urinary Symptoms
20%
Percentage Improvement
20%
Lower Urinary Tract Symptoms
10%
Randomized Trial
10%
Treatment Options
10%
Headache
10%
Patient Outcomes
10%
Active Control
10%
Patient Characteristics
10%
Urodynamics
10%
Dizziness
10%
Microwave Treatment
10%
MEDLINE
10%
Cochrane Library
10%
Urinary Flow
10%
International Prostate Symptom Score
10%
Exclusion Criteria
10%
Asthenia
10%
Data Pooling
10%
Urologic Symptoms
10%
Specialized Databases
10%
Treatment Discontinuation
10%
Tamsulosin
10%
Bothersome Symptoms
10%
Urine Flow Rate
10%
Postural Hypotension
10%
Inpatient Treatment
10%
American Urological Association Symptom Score
10%
Fold Increase
10%
Urological Symptoms
10%
Efficacy Outcomes
10%
Symptom Treatment
10%
Flow Measure
10%
Medicine and Dentistry
Prostate Hypertrophy
100%
Terazosin
100%
Placebo
100%
Obstruction
54%
Alpha Adrenergic Receptor Blocking Agent
54%
Pilus
54%
Adverse Effect
45%
Urinary System
18%
Transurethral Microwave Thermotherapy
18%
Urodynamics
9%
Lower Urinary Tract Symptom
9%
Systematic Review
9%
Patient Characteristics
9%
Orthostatic Hypotension
9%
Urine Flow Rate
9%
International Prostate Symptom Score
9%
Microwave Thermotherapy
9%
Headache
9%
Dizziness
9%
Asthenia
9%
American Urological Association Symptom Index
9%
Tamsulosin
9%
Treatment Option
9%
Side Effect
9%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Prostate Hypertrophy
100%
Terazosin
100%
Obstruction
54%
Alpha Adrenergic Receptor Blocking Agent
54%
Finasteride
54%
Adverse Effect
45%
Tamsulosin
9%
Headache
9%
Dizziness
9%
Orthostatic Hypotension
9%
Asthenia
9%
Lower Urinary Tract Symptom
9%
Side Effect
9%
Neuroscience
Hyperplasia
100%
Placebo
100%
Terazosin
100%
Alpha Blocker
54%
Finasteride
54%
Adverse Effect
45%
Urological
18%
Headache
9%
Tamsulosin
9%
Side Effect
9%
Systematic Review
9%
Hypotension
9%
Agricultural and Biological Sciences
Placebo
100%
Terazosin
100%
Finasteride
54%
Alpha Blocker
54%
Adverse Effects
45%
Urinary System
27%
Systematic Review
9%
Urine Flow Rate
9%
Headache
9%
Orthostatic Hypotension
9%
Data Processing
9%
Tamsulosin
9%